Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;25(1):78-86.
doi: 10.1634/theoncologist.2019-0365. Epub 2019 Sep 6.

Patient Preferences for Use of Archived Biospecimens from Oncology Trials When Adequacy of Informed Consent Is Unclear

Affiliations

Patient Preferences for Use of Archived Biospecimens from Oncology Trials When Adequacy of Informed Consent Is Unclear

Jeffrey Peppercorn et al. Oncologist. 2020 Jan.

Abstract

Background: Oncology research increasingly involves biospecimen collection and data sharing. Ethical challenges emerge when researchers seek to use archived biospecimens for purposes that were not well defined in the original informed consent document (ICD). We sought to inform ongoing policy debates by assessing patient views on these issues.

Materials and methods: We administered a cross-sectional self-administered survey to patients with cancer at an academic medical center. Survey questions addressed attitudes toward cancer research, willingness to donate biospecimens, expectations regarding use of biospecimens, and preferences regarding specific ethical dilemmas.

Results: Among 240 participants (response rate 69%), virtually all (94%) indicated willingness to donate tissue for research. Most participants (86%) expected that donated tissue would be used for any research deemed scientifically important, and virtually all (94%) expected that the privacy of their health information would be protected. Broad use of stored biospecimens and data sharing with other researchers increased willingness to donate tissue. For three scenarios in which specific consent for proposed biobank research was unclear within the ICD, a majority of patient's favored allowing the research to proceed: 76% to study a different cancer, 88% to study both inherited (germline) and tumor specific (somatic) mutations, and 70% to permit data sharing. A substantial minority believed that research using stored biospecimens should only proceed with specific consent.

Conclusion: When debates arise over appropriate use of archived biospecimens, the interests of the research participants in seeing productive use of their blood or tissue should be considered, in addition to addressing concerns about potential risks and lack of specific consent.

Implications for practice: This survey evaluated views of patients with cancer regarding the permissible use of stored biospecimens from cancer trials when modern scientific methods are not well described in the original informed consent document. The vast majority of patients support translational research and expect that any biospecimens they donate will be used to advance knowledge. When researchers, policy makers, and those charged with research oversight debate use of stored biospecimens, it is important to recognize that research participants have an interest in productive use of their blood, tissue, or data, in addition to considerations of risks and the adequacy of documented consent.

Keywords: Biobank; Cancer trials; Informed consent; Patient survey; Research ethics.

PubMed Disclaimer

Conflict of interest statement

Disclosures of potential conflicts of interest may be found at the end of this article.

Figures

Figure 1
Figure 1
General views of medical research among patients with cancer.
Figure 2
Figure 2
Factors impacting willingness to donate tissue for research.
Figure 3
Figure 3
Patient views on use archived biospecimens when proposed research conflicts with the consent document. Abbreviation: ICD, informed concent document.

Similar articles

Cited by

References

    1. Vaught J, Rogers J, Myers K et al. An NCI perspective on creating sustainable biospecimen resources. J Natl Cancer Inst Monogr 2011;2011:1–7. - PubMed
    1. Beskow LM, Lin L, Dombeck CB et al. Improving biobank consent comprehension: A national randomized survey to assess the effect of a simplified form and review/retest intervention. Genet Med 2017;19:505–512. - PMC - PubMed
    1. Strech D, Bein S, Brumhard M et al. A template for broad consent in biobank research. Results and explanation of an evidence and consensus‐based development process. Eur J Med Genet 2016;59:295–309. - PubMed
    1. Grady C, Eckstein L, Berkman B et al. Broad consent for research with biological samples: Workshop conclusions. Am J Bioeth 2015;15:34–42. - PMC - PubMed
    1. Caulfield T, Murdoch B. Genes, cells, and biobanks: Yes, there's still a consent problem. PLoS Biol 2017;15:e2002654. - PMC - PubMed

Publication types